Skip to content
Home/Companies/Biotech/Amphista Therapeutics
AT

Amphista Therapeutics

Biotech·UK·Active·4yr hold

Amphista Therapeutics is a biotech company, headquartered in UK.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Amphista Therapeutics?

Amphista Therapeutics is currently owned by SV Health Managers through Dementia Discovery Fund (2015 vintage), since 2022.

Hand-verified · updated 2026-07-16

SV Health Managers
Investor
SV Health Managers
Dementia Discovery Fund · 2015 · Impact

Key facts

HQUK
SectorBiotech
StatusActive

More from Dementia Discovery Fund

Other portfolio companies in the same fund.

Montara Therapeutics
Active
BiotechUnited States· 2024
TRIMTECH Therapeutics
Active
BiotechUK· 2023
AviadoBio
Active
BiotechUK· 2021
Harness Therapeutics
Active
BiotechUK· 2020
NRG Therapeutics
Active
BiotechUK· 2020
QurAlis
Active
BiotechUnited States· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Adcendo
Active
Jeito CapitalDenmark· 2026
Data refreshed weekly · Sourced from public filings